Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials.
作者信息
Di Minno Matteo N D, Ambrosino Pasquale, Lupoli Roberta, Di Minno Alessandro, Dentali Francesco
机构信息
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Unit of Cell and Molecular Biology in Cardiovascular Diseases, "Monzino" Cardiology Centre, IRCCS, Milan, Italy.
出版信息
Blood Transfus. 2015 Jul;13(3):391-5. doi: 10.2450/2014.0184-14. Epub 2014 Nov 25.
Abstract
摘要
相似文献
1
Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials.直接口服抗凝剂治疗非诱因性静脉血栓栓塞症：一项随机对照试验的荟萃分析
Blood Transfus. 2015 Jul;13(3):391-5. doi: 10.2450/2014.0184-14. Epub 2014 Nov 25.
2
Aspirin for prevention and treatment of venous thromboembolism.阿司匹林用于预防和治疗静脉血栓栓塞症。
Blood Rev. 2014 May;28(3):103-8. doi: 10.1016/j.blre.2014.03.003. Epub 2014 Apr 1.
3
Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism.接受直接口服抗凝剂治疗静脉血栓栓塞症的女性出现异常子宫出血。
Vascul Pharmacol. 2017 Aug;93-95:1-5. doi: 10.1016/j.vph.2017.05.001. Epub 2017 May 4.
4
The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations.新型口服抗凝剂治疗静脉血栓栓塞症：警告与局限性
Blood Transfus. 2015 Apr;13(2):178-80. doi: 10.2450/2015.0002-15.
5
[New oral anticoagulants for treatment of venous thromboembolism].用于治疗静脉血栓栓塞症的新型口服抗凝剂
Dtsch Med Wochenschr. 2011 Jun;136(22):1162-4. doi: 10.1055/s-0031-1280530. Epub 2011 May 24.
6
Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.体重对直接口服抗凝剂治疗急性静脉血栓栓塞症患者疗效和安全性的影响：一项随机对照试验的荟萃分析
Ann Med. 2015 Feb;47(1):61-8. doi: 10.3109/07853890.2014.982064. Epub 2015 Feb 9.
7
Cancer and clots: all cases of venous thromboembolism are not treated the same.癌症与血栓：并非所有静脉血栓栓塞病例的治疗方式都相同。
Cleve Clin J Med. 2009 Feb;76(2):129-35. doi: 10.3949/ccjm.75a.07160.
8
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].达比加群：血栓栓塞性疾病治疗与预防的一种新治疗选择？
Dtsch Med Wochenschr. 2010 Feb;135(6):256-9. doi: 10.1055/s-0030-1247864. Epub 2010 Jan 26.
9
Real world experience at a single centre using low dose direct oral anticoagulants after unprovoked venous thromboembolism.
Br J Haematol. 2019 Aug;186(3):e39-e41. doi: 10.1111/bjh.15880. Epub 2019 Mar 28.
10
Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism.肾功能与静脉血栓栓塞症的直接口服抗凝治疗。
Am J Med. 2017 Oct;130(10):1137-1143. doi: 10.1016/j.amjmed.2017.06.004. Epub 2017 Jul 4.
引用本文的文献
1
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗深静脉血栓形成的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3.
2
Clinical epidemiology of venous thromboembolic disease: An institutional registry.静脉血栓栓塞性疾病的临床流行病学：一项机构登记研究。
Front Cardiovasc Med. 2022 Jul 22;9:928094. doi: 10.3389/fcvm.2022.928094. eCollection 2022.
3
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.诱发性与非诱发性静脉血栓栓塞：来自GARFIELD-VTE研究的结果
Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb.
4
Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.忽略而非追逐华法林管理中的凝血因子 VII：一项中断时间序列研究。
Blood. 2021 May 20;137(20):2745-2755. doi: 10.1182/blood.2020008698.
5
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.美国血液学会2020年静脉血栓栓塞管理指南：深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
6
Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.原发性脑肿瘤或继发性脑转移瘤患者的治疗性抗凝。
Oncologist. 2018 Apr;23(4):468-473. doi: 10.1634/theoncologist.2017-0274. Epub 2017 Nov 20.
本文引用的文献
1
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.达比加群或华法林治疗急性静脉血栓栓塞症及汇总分析。
Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16.
2
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.新型口服抗凝剂与维生素 K 拮抗剂治疗急性有症状静脉血栓栓塞症的有效性和安全性：系统评价和荟萃分析。
J Thromb Haemost. 2014;12(3):320-8. doi: 10.1111/jth.12485.
3
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.依度沙班与华法林治疗有症状的静脉血栓栓塞症。
N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31.
4
Identifying risk factors for venous thromboembolism.
Circulation. 2012 May 1;125(17):2051-3. doi: 10.1161/CIRCULATIONAHA.112.102814. Epub 2012 Apr 3.
5
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.利伐沙班口服治疗有症状的肺栓塞。
N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26.
6
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism.早发性特发性静脉血栓栓塞患者代谢综合征主要成分的患病率异常高。
Thromb Res. 2011 Mar;127(3):193-7. doi: 10.1016/j.thromres.2010.12.005. Epub 2011 Jan 13.
7
Oral rivaroxaban for symptomatic venous thromboembolism.口服利伐沙班治疗有症状的静脉血栓栓塞症。
N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3.
8
Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.遗传性血栓形成倾向：对静脉血栓栓塞症的预防和治疗的影响。
Semin Thromb Hemost. 2009 Oct;35(7):683-94. doi: 10.1055/s-0029-1242722.
9
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.达比加群酯与华法林治疗急性静脉血栓栓塞症的比较。
N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598.
10
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目：PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
Zotero 插件